Clinical Trials Browser

Phase 2 × Spinocerebellar Degenerations × Bevacizumab × Clear all

NCT06784947 2025-10-02

Trial of Atezolizumab, Bevacizumab, and Tiragolumab in Patients With Microsatellite Stable, Metastatic Colorectal Cancer

Phase 2 Active not recruiting

Gastrointestinal

Spinocerebellar Degenerations, Colorectal Neoplasms

NCT06835179 2025-02-19

SBRT Combined With CAPEOX, Bevacizumab, and PD-1 Inhibitor for the Treatment of RAS-Mutant, MSS-Type, Unresectable Metastatic Colorectal Cancer.

Phase 2 Not yet recruiting

Gastrointestinal

Spinocerebellar Degenerations, Colorectal Neoplasms